AI CuratorAI-generated

Research summary · 9 d ago

AI summary · not yet reviewedSubjects not reportedObservationalTrial registry record – peer review not applicable

Central Vein Sign in MRI for MS Diagnosis

A research study is underway to evaluate the Central Vein Sign (CVS) in MRI as a potential diagnostic biomarker for multiple sclerosis (MS). The study aims to determine if CVS can provide greater sensitivity and specificity for diagnosing MS, especially in patients who do not fit the existing diagnostic criteria.

Tags: #MSResearch
Most relevant to: —
Source: Read original source

This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Human efficacy: Not yet assessed
Mechanism: Not yet assessed
Evidence strength: Not yet assessed
Outcome: Not yet assessed

Why it matters

This research could enable earlier and more accurate diagnoses for MS, facilitating timely interventions for patients presenting with atypical symptoms.

What this does not prove

As no results are posted yet, the effectiveness of CVS as a diagnostic tool remains unconfirmed, and we cannot draw any conclusions regarding its accuracy or usefulness in clinical practice.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Observational
Participants / samples: Not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: Not reported
Evidence reviewed: Trial registry record
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Trial registrationCentral Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis ↗

Supporting passages (3)

study designStudy investigators will confirm eligibility criteria, and participants will then be enrolled into the study.",

findings"description": "MRI will be done to assess sensitivity and specificity of the CVS for multiple sclerosis.\n\nMRI will be done at baseline or start of the study and at month 24, end of study.

limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.